Multidrug resistance: A solvable problem?

Annals of Oncology

Volumn 10, Issue SUPPL. 4, 1999, Pages

  Borst, Piet ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Drugresistance; MRP; P glycoprotein

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CARRIER PROTEIN; EPIPODOPHYLLOTOXIN DERIVATIVE; GLYCOPROTEIN P; PACLITAXEL; VINCA ALKALOID;

ANTINEOPLASTIC ACTIVITY; CANCER RESISTANCE; CONFERENCE PAPER; DRUG RESEARCH; DRUG TRANSPORT; HUMAN; MULTIDRUG RESISTANCE; PANCREAS CANCER; PRIORITY JOURNAL;

EID: 0032815518     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/10.suppl_4.S162     Document Type: Conference Paper

References (13)

1. Pancreatic Cancer: Molecular and Clinical Advances. 1996. Eds. Neoptolemos JP, Lemoine NR. Blackwell Science Ltd., Oxford, UK.
2. Borst P. Editor's introduction. Seminars in Cancer Biol 1997; 8: 131-4.
3. Schinkel AH, Mayer U, Wagenaar E et al. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Natl. Acad. Sci. USA 1997; 94: 4028-33.
4. Mickley LA, Lee J, Weng Z et al. Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselecled and drug-selected cell lines, and human tumors. Blood 1998; 91: 1749-56.
5. Deeley RG, Cole SPC. Function, evolution and structure of Multidrug Resistance Protein (MRP). Seminars in Cancer Biol 1997; 8: 193-204.
6. Wijnholds J, Evers R, Van Leusden MR et al. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking MRP. Nature Med 1997; 11: 1275-9.
7. Wijnholds J, Scheffer GL, Van der Valk et al. Multidrug resistance protein I protects the oropharyngeal mucosal layer and the testicular tubulesagainst drug-induced damage. J Exp Med 1998; 188: 797-808.
8. Borst P, Kool M, Evers R. Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR? Seminars in Cancer Biol 1997; 8: 205-13.
9. Kool M, Van der Linden M, De Haas M et al. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res 1998; in press.
10. Suwa H, Ohshio G, Arao S et al. Immunohistochemical localization of P-glycoprotein and expression of the multidrug resistance-1 gene in human pancreatic cancer: relevance to indicator of better prognosis. Jpn J Cancer Res 1996; 87: 641-9.
11. Tomikawa M, Kubota T, Takahashi S et al. Chemosensitivity of human pancreatic cancer cell lines serially transplanted in nude mouse. Anticancer Res 1998; 18: 1059-62.
12. Miller DW, Fontain M, Kolar C et al. The expression of multidrug resistance-associated protein (MRP) in pancreatic adenocarcinoma cell lines. Cancer Lett 1996; 107:301-6.
13. Verovski VN, Van den Berge DL, Delvaeye MM et al. Low-level doxorubicin resistance in P-glycoprotein-negative human pancreatic tumour PSN1/ADR cells implicates a brefelding A-sensitive mechanism of drug extrusion. Br J Cancer 1996; 73: 596-602.